Last 23 quarters of trend data · Healthcare · Medical - Healthcare Plans
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -18.07 | 6.48 | 1.39 | — | — | — | 3.56 | — | — | 21.97 | 6.00 | — | — | — | — | — | — | — | — | — | — |
| — | — | -61.1% | — | — | — | -40.6% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 0.68 | 0.49 | 0.20 | 0.36 | 0.41 | 0.51 | 0.33 | 0.37 | 0.53 | 0.54 | 0.51 | 0.36 | 0.22 | 0.29 | 0.24 | 0.13 | 0.26 | 0.21 | 0.52 | 0.79 | 1.96 |
| — | -3.7% | -38.2% | -2.8% | -22.7% | -6.6% | -35.4% | +2.9% | +146.5% | +86.5% | +111.2% | +184.5% | -17.2% | +36.9% | -53.5% | -83.9% | -86.7% | -89.5% | -85.4% | — | — | |
| P/B Ratio | 8.17 | 4.63 | 2.27 | 4.15 | 4.78 | 4.99 | 3.00 | 3.52 | 4.42 | 4.22 | 4.22 | 2.58 | 1.35 | 1.86 | 1.52 | 0.59 | 0.98 | 0.72 | 1.57 | 1.18 | 2.33 |
| — | -7.3% | -24.4% | +18.1% | +8.0% | +18.3% | -28.9% | +36.4% | +228.1% | +127.0% | +177.4% | +334.5% | +37.7% | +158.2% | -3.2% | -49.8% | -58.0% | -72.0% | -49.1% | — | — | |
| P/FCF | 7.48 | 1.17 | 0.36 | 1.54 | — | 2.90 | 1.15 | 2.63 | — | 2.46 | 1.74 | 1.79 | — | 2.76 | 0.87 | 0.92 | — | 1.08 | 0.94 | 15.09 | — |
| — | -59.7% | -68.6% | -41.6% | — | +18.0% | -33.6% | +47.1% | — | -11.2% | +99.6% | +94.7% | — | +156.7% | -7.7% | -93.9% | — | -95.2% | -78.7% | — | — | |
| EV / EBITDA | — | 3.77 | -0.21 | — | — | — | 1.71 | — | — | 10.36 | 3.27 | — | — | — | — | — | — | — | — | — | — |
| — | — | -112.2% | — | — | — | -47.8% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | 3.78 | -0.21 | — | — | — | 1.76 | — | — | 10.61 | 3.30 | — | — | — | — | — | — | — | — | — | — |
| — | — | -111.9% | — | — | — | -46.7% | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 14.4% | 100.0% | 30.5% | 6.6% | 13.4% | 10.9% | 25.8% | 13.7% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| — | +821.0% | +18.1% | -51.8% | -86.6% | -89.1% | -74.2% | -86.3% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | |
| Operating Margin | -3.4% | 7.8% | 15.2% | -11.9% | -4.3% | -8.0% | 9.8% | -6.2% | -2.2% | 2.7% | 8.3% | -10.5% | -4.5% | -0.9% | -2.6% | -21.9% | -19.2% | -10.6% | -7.5% | -38.1% | -45.9% |
| — | +197.5% | +55.3% | -92.7% | -100.5% | -393.0% | +17.1% | +41.3% | +52.0% | +393.1% | +425.5% | +52.0% | +76.5% | +91.1% | +65.9% | +42.5% | +58.2% | +20.1% | +66.9% | +62.4% | — | |
| Net Margin | -3.8% | 7.4% | 14.6% | -12.6% | -4.6% | -8.0% | 9.0% | -6.4% | -2.3% | 2.5% | 8.3% | -10.5% | -4.5% | -1.0% | -2.7% | -21.8% | -18.9% | -10.6% | -7.4% | -38.3% | -45.8% |
| — | +193.0% | +61.7% | -95.9% | -104.3% | -414.8% | +9.2% | +38.8% | +50.4% | +348.2% | +405.9% | +51.9% | +76.0% | +90.4% | +63.6% | +43.2% | +58.6% | +20.5% | +67.5% | +62.1% | — |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -44.4% | 19.4% | 51.3% | -35.1% | -12.6% | -18.3% | 23.4% | -14.1% | -4.7% | 5.2% | 19.3% | -17.4% | -7.0% | -1.6% | -4.4% | -22.9% | -16.5% | -8.7% | -5.5% | -13.5% | -12.9% |
| — | +206.3% | +119.2% | -149.5% | -165.3% | -453.8% | +21.4% | +19.0% | +32.2% | +413.5% | +542.0% | +24.0% | +57.8% | +81.0% | +20.9% | -68.9% | -28.5% | -108.4% | +84.8% | — | — | |
| ROA | -7.9% | 3.5% | 8.7% | -5.8% | -2.3% | -3.7% | 5.2% | -3.3% | -1.2% | 1.2% | 4.4% | -4.3% | -1.7% | -0.3% | -0.9% | -5.1% | -4.3% | -2.5% | -2.0% | -6.1% | -6.2% |
| — | +194.4% | +68.8% | -77.4% | -96.9% | -413.2% | +16.5% | +23.7% | +30.4% | +447.5% | +601.0% | +15.6% | +61.2% | +86.1% | +54.9% | +16.7% | +30.8% | -22.7% | +35.3% | +26.5% | — | |
| ROIC | — | — | — | — | — | — | — | -468.0% | -15.2% | — | — | — | — | — | — | — | — | — | — | -38.9% | -59.0% |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.44 | 0.21 | 0.26 | 0.44 | 0.67 | 0.26 | 0.22 | 0.29 | 0.26 | 0.26 | 0.29 | 0.37 | 0.32 | 0.31 | 0.32 | 0.33 | 0.27 | 0.24 | 0.22 | — | — |
| — | -18.7% | +15.2% | +48.8% | +160.1% | -1.5% | -22.4% | -20.5% | -20.7% | -16.3% | -9.7% | +11.0% | +18.0% | +31.5% | +43.7% | — | — | — | — | — | — | |
| Debt / EBITDA | — | 1.11 | 0.61 | — | — | — | 0.99 | — | — | 4.36 | 1.60 | — | — | — | — | — | — | — | — | — | — |
| — | — | -38.6% | — | — | — | -38.5% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 0.95 | 1.08 | 1.09 | 1.10 | 1.10 | 0.89 | 0.91 | 0.82 | 0.80 | — | — | — | 1.45 | 1.29 | — | 1.26 | 1.38 | — | — | — | — |
| — | +21.7% | +19.7% | +33.5% | +37.2% | — | — | — | -44.8% | — | — | — | +5.3% | — | — | — | — | — | — | — | — | |
| Quick Ratio | 0.95 | 1.08 | 1.09 | 1.10 | 1.10 | 0.89 | 0.91 | 0.82 | 0.80 | — | — | — | 1.45 | 1.29 | — | 1.26 | 1.38 | — | — | — | — |
| — | +21.7% | +19.7% | +33.5% | +37.2% | — | — | — | -44.8% | — | — | — | +5.3% | — | — | — | — | — | — | — | — | |
| Interest Coverage | -23.85 | 82.34 | 130.81 | -322.50 | -19.31 | -38.94 | 49.08 | -24.50 | -8.00 | 11.17 | 31.24 | -23.23 | -9.57 | -1.33 | -5.13 | -36.05 | -30.86 | -17.21 | -16.96 | -498.63 | -531.86 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 23 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying OSCR stock.
Oscar Health, Inc.'s current P/E is -18.1x. The average P/E over the last 2 quarters is 3.9x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Oscar Health, Inc.'s current operating margin is -3.4%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Oscar Health, Inc.'s business trajectory between earnings reports.